ACHIEVE LIFE SCIENCES INC. - COMMON SHARES

Achieve Life Sciences to Announce Fourth Quarter and Year-End 2022 Financial Results and Host Conference Call and Webcast on March 16, 2023

02 3 2023 08:00:01 提供 Nasdaq GlobeNewswire

Achieve Life Sciences Announces Last Subject Dosed in Phase 2 ORCA-V1 Trial of Cytisinicline for e-Cigarette Cessation

07 2 2023 08:00:01 提供 Nasdaq GlobeNewswire

Achieve Life Sciences to Participate at the 2023 SVB Securities Global Biopharma Conference

02 2 2023 08:00:01 提供 Nasdaq GlobeNewswire

Achieve Life Sciences Announces Granting of New Hire Inducement Award

27 1 2023 16:30:00 提供 Nasdaq GlobeNewswire

Achieve Life Sciences Announces Last Subject Dosed in Phase 3 ORCA-3 Trial of Cytisinicline for Smoking Cessation

09 1 2023 08:00:01 提供 Nasdaq GlobeNewswire

Achieve Life Sciences Announces Patent Granted by USPTO for New Cytisinicline Formulation

21 12 2022 08:00:00 提供 Nasdaq GlobeNewswire

Achieve Life Sciences Announces Private Placement of $18.9 Million

15 11 2022 08:00:02 提供 Nasdaq GlobeNewswire

Achieve Reports Financial Results for Third Quarter 2022 and Provides Corporate Update

14 11 2022 16:05:01 提供 Nasdaq GlobeNewswire

Achieve Announces Early Completion of Target Enrollment in Cytisinicline e-Cigarette Cessation Trial

08 11 2022 08:00:03 提供 Nasdaq GlobeNewswire

Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 14, 2022

31 10 2022 08:00:01 提供 Nasdaq GlobeNewswire

Achieve Announces Completion of Target Enrollment in the Phase 3 ORCA-3 Trial of Cytisinicline for Smoking Cessation

27 9 2022 08:00:00 提供 Nasdaq GlobeNewswire

Achieve Life Sciences Announces Participation at Fall Investor Conferences

07 9 2022 08:00:02 提供 Nasdaq GlobeNewswire

Achieve Reports Financial Results for Second Quarter 2022 and Provides Corporate Update

11 8 2022 16:05:01 提供 Nasdaq GlobeNewswire

Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 11, 2022

28 7 2022 08:00:02 提供 Nasdaq GlobeNewswire

Achieve Life Sciences Announces Granting of New Hire Inducement Awards

01 7 2022 16:05:00 提供 Nasdaq GlobeNewswire

Achieve Life Sciences Announces Initiation of Phase 2 ORCA-V1 Clinical Trial Evaluating Cytisinicline for Nicotine e-cigarette Cessation

29 6 2022 08:00:00 提供 Nasdaq GlobeNewswire

Achieve Life Sciences Announces Participation at H.C. Wainwright 1st Annual Mental Health Conference

21 6 2022 08:00:00 提供 Nasdaq GlobeNewswire

Achieve Life Sciences Awarded Grant from the National Institutes of Health to Conduct Phase 2 Trial of Cytisinicline in Nicotine e-cigarette Users

01 6 2022 08:00:01 提供 Nasdaq GlobeNewswire

Achieve Life Sciences Announces Participation at LD Micro Invitational Conference

26 5 2022 08:00:00 提供 Nasdaq GlobeNewswire

Achieve Life Sciences Announces Participation at Best Ideas Virtual Investor Conference

13 5 2022 08:00:00 提供 Nasdaq GlobeNewswire